Paragraph 123 I1
United Kingdom
Before regulation 156 insert—
“Amendment of regulation 196 (urgent action)
156ZAIn regulation 196—
(a)in the italic heading immediately preceding it, after “Urgent action” insert “ and major safety review ”;
(b)in paragraph (1), for “The licensing authority must initiate the Section 4 procedure by informing” substitute “ In the case of a medicinal product authorised for sale or supply under a UKMA(NI), UKMA(UK), THR(NI), THR(UK) or Article 126a authorisation, the licensing authority must inform ”;
(c)omit sub-paragraph (2B);
(d)omit paragraphs (4) to (7);
(e)in paragraph (8), omit the definition of “EU urgent action procedure” and “Section 4 procedure”.”.
Annotations
Commencement
- I1
Sch. 2 para. 123 in force at 31.12.2020 immediately before IP completion day, see reg. 1